ARTICLE | Company News
Cytel other research news
May 17, 1999 7:00 AM UTC
CYTL's Epimmune Inc. subsidiary received a five-year $2.25 million grant from the National Institute of Allergy and Infectious Diseases to develop epitope-based vaccines using Epimmune's EIS, which a...